Sutter Martin P's Form 4 filing
Abiomed IncABMD · filed Feb 17, 2022
- Accession no.
- 0001179110-22-001400
- Filed
- Feb 17, 2022
- Trade date
- Feb 17, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 11 non-derivative transactions. Open-market sales total $1.26M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sutter Martin PCIK 0001017832 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −260 | $307.64F1 | −$79,986.4 | 134,130 | Direct | |
| Feb 17, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −424 | $308.80F2 | −$130,931.2 | 133,706 | Direct | |
| Feb 17, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −328 | $309.74F3 | −$101,594.72 | 133,378 | Direct | |
| Feb 17, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −254 | $310.65F4 | −$78,905.1 | 133,124 | Direct | |
| Feb 17, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −346 | $311.69F5 | −$107,844.74 | 132,778 | Direct | |
| Feb 17, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −193 | $312.64F6 | −$60,339.52 | 132,585 | Direct | |
| Feb 17, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −48 | $313.82F7 | −$15,063.36 | 132,537 | Direct | |
| Feb 17, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −798 | $316.02F8 | −$252,183.96 | 131,739 | Direct | |
| Feb 17, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −147 | $316.92F9 | −$46,587.24 | 131,592 | Direct | |
| Feb 17, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −1,153 | $320.61F10 | −$369,663.33 | 130,439 | Direct | |
| Feb 17, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −49 | $321.61F11 | −$15,758.89 | 130,390 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This price represents the sale price of the transactions on the reported date at $307.63. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F2
This price represents the sale price of the transactions on the reported date at $308.79. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F3
This price represents the sale price of the transactions on the reported date at $309.73. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F4
This price represents the sale price of the transactions on the reported date at $310.64. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F5
This price represents the sale price of the transactions on the reported date at $311.69. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F6
This price represents the sale price of the transactions on the reported date at $312.63. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F7
This price represents the sale price of the transactions on the reported date at $313.82. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F8
This price represents the sale price of the transactions on the reported date at $316.01. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F9
This price represents the sale price of the transactions on the reported date at $316.91. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F10
This price represents the sale price of the transactions on the reported date at $320.60. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.
- F11
This price represents the sale price of the transactions on the reported date at $321.61. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Referenced by the price of 1 transaction in Table I.